Arabic Arabic English English French French German German
dark

New BRCA-targeting drug could offer hope in treating advanced prostate cancer

Talazoparib, a new precision drug, can keep cancer in check in some men with advanced prostate cancer who have run out of options, a phase II clinical trial shows. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Al-Qassim: 500,000+ Beneficiaries of «Taakkad» Centers to Date

Next Post

Students’ lack of routine vaccines muddies start of school

Related Posts
Total
0
Share